BindingDB logo
myBDB logout

null

SMILES: CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O

InChI Key: InChIKey=JPDLPQUDPUKPTI-LSDHHAIUSA-N

Find this compound or compounds like it in BindingDB or PDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 12 hits for monomerid = 325495   
Target/Host
(Institution)
LigandTarget/Host
Links
Ligand
Links
Trg + Lig
Links
Ki
nM
ΔG°
kcal/mole
IC50
nM
Kd
nM
EC50/IC50
nM
koff
s-1
kon
M-1s-1
pHTemp
°C
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



Array BioPharma Inc.

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10189845 (2019)


BindingDB Entry DOI: 10.7270/Q2Z03B7Q
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



Array BioPharma Inc.

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10189845 (2019)


BindingDB Entry DOI: 10.7270/Q2Z03B7Q
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



Array BioPharma Inc.

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10189845 (2019)


BindingDB Entry DOI: 10.7270/Q2Z03B7Q
More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



Array BioPharma Inc.

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10189845 (2019)


BindingDB Entry DOI: 10.7270/Q2Z03B7Q
More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



Array BioPharma Inc.; Celgene Corporation

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10730880 (2020)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



ARRAY BIOPHARMA INC.; CELGENE CORPORATION

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US11028093 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



Array BioPharma Inc.; Celgene Corporation

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10730880 (2020)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK3


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 5.50E+3n/an/an/an/an/an/a



Array BioPharma Inc.; Celgene Corporation

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK3 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10730880 (2020)

More data for this
Ligand-Target Pair
Non-receptor tyrosine-protein kinase TYK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



ARRAY BIOPHARMA INC.; CELGENE CORPORATION

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit Tyk2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US11028093 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 550n/an/an/an/an/an/a



ARRAY BIOPHARMA INC.; CELGENE CORPORATION

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US11028093 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK2


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 55n/an/an/an/an/an/a



ARRAY BIOPHARMA INC.; CELGENE CORPORATION

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK2 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US11028093 (2021)

More data for this
Ligand-Target Pair
Tyrosine-protein kinase JAK1


(Homo sapiens (Human))
BDBM325495
PNG
(US10189845, Example 157A | US10730880, Example 157...)
Show SMILES CCC(CC)n1cc(cn1)-c1nc(cn2nccc12)-c1cnn(c1)[C@@H](C)[C@@H](C)O |r|
Show InChI InChI=1S/C21H27N7O/c1-5-18(6-2)27-12-17(10-24-27)21-20-7-8-22-28(20)13-19(25-21)16-9-23-26(11-16)14(3)15(4)29/h7-15,18,29H,5-6H2,1-4H3/t14-,15+/m0/s1
PDB

Reactome pathway
KEGG

UniProtKB/SwissProt

B.MOAD
DrugBank
antibodypedia
GoogleScholar
AffyNet 
PC cid
PC sid
UniChem
US Patent
n/an/a 550n/an/an/an/an/an/a



Array BioPharma Inc.; Celgene Corporation

US Patent


Assay Description
Compounds of Formula I were screened for their ability to inhibit JAK1 using the general enzyme inhibition assay method, in which the assay mixture c...


US Patent US10730880 (2020)

More data for this
Ligand-Target Pair